DEC 11, 2017 7:46 AM PST

First-Ever Gene Therapy for Babies with "Bubble Boy" Disease

WRITTEN BY: Kara Marker

There is a genetic disorder affecting the immune system so severely that its patients often require protective isolation, hence the disease’s nickname: “Bubble Boy Disease.” Scientists know this disease as X-linked severe combined immunodeficiency disorder (XSCID). From the St. Jude Children’s Research Hospital, scientists conduct the first-ever clinical trial in infants with XSCID to test the effectiveness of the newest gene therapy approach to treating the disease.

XSCID gene therapy has been well tolerated and effective for infants as young as 2 months old. Credit: St. Jude Children's Research Hospital

Babies born with XSCID have a mutation in the IL2RG gene, which is normally responsible for making a protein called the “common gamma chain.” Without this protein, the immune system’s function is critically impaired, as immune cells like T cells, B cells, and natural killer cells fail to effectively grow and mature. XCID affects a disproportionate amount of boys, and untreated individuals die of infections without an immune system for protection.

Current treatment for XSCID relies on something that more than 80 percent of XSCID patients don’t even have: a tissue-matched sibling donor for transplantation. Incomplete genetic matches such as parents can act as donors, but the transplantation is fraught with complications and the procedure is much less likely to effectively rejuvenate the immune system.

The new gene therapy from St. Jude provides an alternative to a tissue-matched sibling donor. Researchers instead developed a lentiviral vector, which carries a normal copy of the IL2RG gene and delivers it into the hematopoietic stem cells of patients with XSCID. This treatment also contains certain features to promote safety and effectiveness.

The treatment process involves remove bone marrow so the hematopoietic stem cells can incubate with the lentiviral vector carrying normal IL2RG. Afterward, the stem cells are returned via transfusion.

The clinical trial at St. Jude enrolled seven patients between the ages of 2 and 13 months old. Four months after treatment, five patients had developed immune systems strong enough where they no longer needed protected isolation, containing near normal levels of T, B, and natural killer cells of the immune system, and nearly all were carrying the normal version of the IL2RG gene.

"These results are an exciting early indication that this gene therapy is well tolerated and effective in infants as young as 2 months old with this devastating inherited immune disorder," explained St. Jude’s Ewelina Mamcarz, MD.

Mamcarz’s co-study leader, Brian Sorrentino, MD, agrees, saying that the findings “reinforce hope that gene therapy will prove to be safe and effective at restoring immune function early in life.”

Sources: Genetics Home Reference, St. Jude Children’s Research Hospital

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
SEP 01, 2020
Genetics & Genomics
Women's Genes May Help Protect Against the Worst Alzheimer's Cases
SEP 01, 2020
Women's Genes May Help Protect Against the Worst Alzheimer's Cases
Women tend to get Alzheimer's more than men, but the female genome gives them some protection from the worst aspects of ...
SEP 13, 2020
Genetics & Genomics
Men and Women Express Many Genes at Different Levels
SEP 13, 2020
Men and Women Express Many Genes at Different Levels
Most humans carry the same genes in their genome, but how are genes expressed differently in men and women?
SEP 17, 2020
Genetics & Genomics
Revealing More About the Past With a New Metagenomic Technique
SEP 17, 2020
Revealing More About the Past With a New Metagenomic Technique
Scientists can use advanced genomics techniques to mine samples for all the genetic material they contain.
NOV 16, 2020
Genetics & Genomics
Hidden Genes in the SARS-CoV-2 Genome
NOV 16, 2020
Hidden Genes in the SARS-CoV-2 Genome
It's essential for organisms to use their genomes to make proteins, and the processes of transcription and translation a ...
NOV 30, 2020
Genetics & Genomics
Green Genetic Technology Can Help Feed the World
NOV 30, 2020
Green Genetic Technology Can Help Feed the World
In the latter half of the last century, agriculture underwent a technological revolution that enabled farmers to create ...
NOV 30, 2020
Cell & Molecular Biology
Can a Scent Motivate Us to Exercise?
NOV 30, 2020
Can a Scent Motivate Us to Exercise?
People are always looking for new ways to get inspired to exercise. Now odor is being proposed as a motivational tool fo ...
Loading Comments...